Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 6,006

Document Document Title
WO/2005/055715A2
Certain noel N-(heteroarylalkyl)alkanediamine derivatives have provided unexpected insecticidal and acaricidal activity. These compounds are represented by formula I: wherein Ar, a, r, R, Ra, Rb, Rc, Rd, b, c, Re, Rf, Rg, Rh, R5, d, e, U...  
WO/2005/054430A2
Hepatitis C virus inhibitors are disclosed having the general formula: (I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are ...  
WO2005025293A3
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides quinazoli...  
WO/2005/054218A1
The present invention relates to β-adrenergic blockers nitrooxyderivatives of general formula (I): A-(Y-ONO2)s and enantiomers and diastereoisomers and pharmaceutically acceptable salts thereof, pharmaceutical compositions containing th...  
WO/2005/051932A1
Arylheterocycle derivatives which are represented by the formula (1): (1) wherein R1 represents C1-6 alkyl, etc.; R2 represents halogeno, etc.; m is an integer of 0 to 4; and T represents a group represented by the formula (2), (3), or (...  
WO2004033440A8
Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl,...  
WO/2005/049546A1
A halogenated bisdiarylaminopolycyclic aromatic compound, polymers made therefrom, and polymeric light emitting diode devices using the polymers are described. The halogenated compound is represented by formula (I), wherein Ar and Ar' ar...  
WO2005019191A3
Compounds having the formula (I), wherein B is (a), (b), (c), or (d); A is a monocyclic or bicyclic ring selected from the group consisting of aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocycle (the other substituents are defined...  
WO2005000231A3
This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).  
WO2005021490A3
The invention relates to N-sulfonyl-alpha-amino-acetic acid derivatives of the general formula (I): including the optical isomers thereof and mixtures of such isomers, wherein Ar1 and Ar2 independently of each other stand for an optional...  
WO/2005/041959A1
The invention features phenoxyacetic acids and analogs of formula (I), compositions containing them, and methods of using them as PPAR modulators to treat or inhibit the progression of, for example, dyslipidemia.  
WO/2005/042493A1
The invention relates to novel hexyl carboxanilides of formula (I), in which L, R1, R3 and A are defined as cited in the description, to several methods for producing said substances, to their use for controlling undesirable micro-organi...  
WO/2005/040101A1
The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to acylurea/sulfonylurea containing compounds and methods for their preparation. These c...  
WO/2005/040100A1
This invention relates to tetrahydro-naphthalene and urea derivatives and salts thereof which are useful as active ingredients of pharmaceutical preparations. The tetrahydro-naphthalene and urea derivatives of the present invention have ...  
WO2005005395A3
Compounds represented by Formula (I) which are useful as are alpha-1A/B adrenoceptor antagonists, to methods of treating conditions associated with the activity of alpha-1A/B adrenoceptors, and to methods of making said compounds, wherei...  
WO2004092116A8
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical...  
WO/2005/037805A2
The present invention relates to a 1,2,4-thiadiazole compound of the formula (I) represented by the formula (1): wherein R¿1? represents C3-C7 alkynyl and X represents C4-C7 straight alkylene optionally substituted with one to four of R...  
WO2004014844A3
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists,...  
WO/2005/037844A1
The inVention is related to new substituted phenyl fused heterocycle compounds having herbicidal activities, these compounds are characterized by high efficiency, low toxicity, high selectivity, and the like.  
WO/2005/035512A1
Antitumor agents containing as the active ingredient thiadiazoline derivatives represented by the general formula (I) or pharmacologically acceptable salts thereof: (I) wherein Z is sulfur or the like; R1 is substituted or unsubstituted ...  
WO2004062601A3
Antibacterial compounds of formula (I) are provided: As well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infectio...  
WO/2005/030736A1
A description follows of 1,3-diones having general formula (I): together with their use as herbicides for the control of weeds in agricultural crops.  
WO2005007636B1
The invention relates to methods for the production and use of novel 1,2,4-thiadiazols of general formulae (I) or (II) as agents for regulating the inhibition of enzymatic urea hydrolysis, wherein R<1> = hydrogen, C1-C8-alkyl or C6-C10-a...  
WO/2005/026139A1
The invention relates to a compound of the formula (I) wherein R represents hydrogen, halogen, alkyl, cycloalkyl, alkoxyalkyl, alkylthioalkyl, haloalkyl, alkoxy, alkylthio, represents optionally substituted phenyl or benzyl, or represent...  
WO/2005/025293A2
Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides quinazoli...  
WO/2005/023183A2
The invention describes novel nitrosated and/or nitrosylated diuretic compounds or pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated diuretic compound, and, optionall...  
WO/2005/023182A2
The invention describes novel nitrosated and/or nitrosylated cardiovascular compounds or pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated cardiovascular compound, an...  
WO2004074270B1
The invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R<1> and R<2>, are as defined herein. The invention also relates to methods of trea...  
WO/2005/021490A2
The invention relates to N-sulfonyl-&agr -amino-acetic acid derivatives of the general formula (I): including the optical isomers thereof and mixtures of such isomers, wherein Ar1 and Ar2 independently of each other stand for an optional...  
WO/2005/020991A1
The present invention relates to compounds of the Formula; wherein R3, R5, R7, U, X, Y and Z are as defined. Compounds of the Formula I have activity inhibiting production of Aβ-peptide. This invention also relates to pharmaceutical com...  
WO2004103278A3
The present invention relates a series of compounds of Formula I, wherein R1, R2, R3, and B are as defined in the specification. The compounds are useful for the inhibition of HIV integrase and for the treatment of AIDS or ARC by adminis...  
WO/2005/021520A1
The invention relates to novel 1,2,4-thiadiazoles of formula (I), in which R1, R2, R3, R4, R5, R6 and A are defined as cited in the description, to methods for producing said compounds and to their use in controlling undesired micro-orga...  
WO2005000309A3
Compounds of the formulae (I) and (II), and pharmaceutically acceptable salts thereof, are found to be inhibitors of sensory neurone specific (SNS) sodium channels. They are therefore useful as analgesic and neuroprotective agents. Formu...  
WO2005000298A3
Provided are aminoaryl substituted 5-membered heterocycle-based p38 kinase, including p38alfa and p38beta. Pharmaceutical compositions containing the compounds are also provided. Method of use of the compounds and compositions are also p...  
WO/2005/019191A2
Compounds having the formula (I), wherein B is (a), (b), (c), or (d); A is a monocyclic or bicyclic ring selected from the group consisting of aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocycle (the other substituents are defined...  
WO/2005/019212A1
The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.  
WO/2005/019184A1
The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.  
WO/2005/019192A1
The invention relates to novel urea derivatives which inhibit tyrosinkinases, especially TIE-2, and Raf kinases and which are used in the treatment of tumors.  
WO/2005/016862A1
A compound represented by the formula (I)[In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C2 to C6 in the aromatic ring (E) independently represent a ring-constituting car...  
WO/2005/016911A1
Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV inhibitors comprising Formula (I), wherein the substituents are as described herein.  
WO/2005/013914A2
The present invention relates to compounds such as those of formula (I-A) inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and met...  
WO2004002491A8
The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.  
WO/2005/012275A2
Certain amidophenyl-sulfanylamino-benzo[1,2,5]thiadiazole compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.  
WO2004060305A3
Novel compounds and methods of using those compounds for the treatment of oncological conditions are provided. In a preferred embodiment, modulation of the activation states of abl or bcr-abl a-kinase proteins comprises the step of conta...  
WO/2005/009940A1
The invention provides novel compounds according to formula I relates to compounds with the general formula I said compounds being useful, e.g. in the treatment of inflammatory, ophthalmic diseases or cancer.  
WO/2005/007636A1
The invention relates to methods for the production and use of novel 1,2,4-thiadiazols of general formulae (I) or (II) as agents for regulating the inhibition of enzymatic urea hydrolysis, wherein R1 = hydrogen, C1-C8-alkyl or C6-C10-ary...  
WO/2005/005374A1
The present invention provides compounds having the formula: (I) wherein R1, R', R2, R3, R3’, R4, X1, X2 and X3 are as defined herein, and pharmaceutical compositions thereof. The present invention also provides methods of inhibiting p...  
WO/2005/006807A1
A wireless microphone communication system (1) comprises a wireless microphone transmitter (91b) and a wireless microphone receiver (11). The wireless microphone transmitter (91b) includes an infrared interface (91c), a control part (91d...  
WO/2005/005395A2
Compounds represented by Formula (I) which are useful as are alpha-1A/B adrenoceptor antagonists, to methods of treating conditions associated with the activity of alpha-1A/B adrenoceptors, and to methods of making said compounds, wherei...  
WO/2005/006806A1
A wireless microphone communication system (1) comprises one or more control apparatuses (21-24) having LAN interfaces; and one or more receiver apparatuses (11-18) having LAN interfaces for receiving radio waves from the transmitter of ...  

Matches 701 - 750 out of 6,006